Which antibiotic binds to the 50S subunit of the bacterial ribosome and could most likely result in the development of pseudomembranous colitis?

Questions 263

ATI RN

ATI RN Test Bank

Lifespan Pharmacology Questions

Question 1 of 5

Which antibiotic binds to the 50S subunit of the bacterial ribosome and could most likely result in the development of pseudomembranous colitis?

Correct Answer: A

Rationale: In the context of lifespan pharmacology, understanding the mechanisms of action of antibiotics is crucial for safe and effective prescribing. In this case, the correct answer is A) Clindamycin. Clindamycin is an antibiotic that binds to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis in bacteria. This mechanism of action disrupts bacterial growth and replication. Regarding the development of pseudomembranous colitis, Clindamycin is particularly associated with this condition due to its ability to disrupt the normal flora of the gut, allowing Clostridium difficile to proliferate and cause colitis. This highlights the importance of considering the potential side effects and complications of antibiotic therapy when making prescribing decisions. Analyzing the other options: B) Tetracycline primarily inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome. C) Vancomycin acts by inhibiting cell wall synthesis in bacteria, targeting D-alanyl-D-alanine residues. D) Amoxicillin disrupts bacterial cell wall synthesis by inhibiting transpeptidase enzymes. Educationally, this question emphasizes the significance of understanding the specific mechanisms of action of antibiotics and their potential side effects. It underscores the need for healthcare providers to make informed decisions when selecting antibiotics to ensure optimal patient outcomes and minimize the risk of complications like pseudomembranous colitis.

Question 2 of 5

Which is the most common type of anemia?

Correct Answer: B

Rationale: In the context of Lifespan Pharmacology, understanding the different types of anemia is crucial for effective patient care. The most common type of anemia worldwide is iron deficiency anemia, making option B the correct answer to the question. Iron is essential for the production of hemoglobin, the protein in red blood cells that carries oxygen. Inadequate iron levels lead to decreased hemoglobin production, resulting in anemia. Option A, folic acid deficiency anemia, is characterized by a lack of folate, which is necessary for red blood cell production. However, it is not the most common type of anemia globally. Option C, B12 deficiency anemia, results from inadequate vitamin B12 levels, which are also required for red blood cell formation. While B12 deficiency is significant, it is not as prevalent as iron deficiency anemia. Option D, sickle cell anemia, is a genetic disorder affecting hemoglobin structure, leading to abnormal red blood cells. While sickle cell anemia is a well-known condition, it is not the most common type of anemia overall. Educationally, grasping the differences between these types of anemia aids in accurate diagnosis and treatment selection. Understanding the prevalence, causes, and symptoms of each type is essential for healthcare professionals when managing patients with anemia. By recognizing iron deficiency anemia as the most common type, clinicians can prioritize screening, prevention, and intervention strategies to address this widespread condition effectively.

Question 3 of 5

The patient who takes insulin has just been prescribed a beta blocker drug. You recognize that the interaction of the beta blocker and the insulin may have which result?

Correct Answer: C

Rationale: In this scenario, the correct answer is C) Masked signs of hypoglycemia. When a patient who is taking insulin is prescribed a beta blocker drug, the beta blocker can mask the typical signs and symptoms of hypoglycemia, such as tachycardia, palpitations, and tremors. This masking effect occurs because beta blockers block the adrenergic response to low blood sugar levels, making it harder for the patient to recognize and respond to hypoglycemia. Option A) Decreased activity of the beta blocker drug is incorrect because the interaction between beta blockers and insulin does not impact the activity of the beta blocker itself. Option B) Enhanced activity of the beta blocker drug is also incorrect as there is no evidence to suggest that insulin would enhance the activity of a beta blocker. Option D) Masked signs of hyperglycemia is incorrect as beta blockers do not typically affect the signs and symptoms of hyperglycemia. From an educational perspective, understanding drug interactions is crucial in pharmacology to ensure patient safety and optimal treatment outcomes. Healthcare providers must be aware of potential interactions between medications to anticipate and manage any adverse effects that may arise. This case highlights the importance of considering how different medications can interact and affect the body's response to various physiological processes.

Question 4 of 5

A patient has been diagnosed with reflux esophagitis (GERD). What instruction by the NP is most appropriate?

Correct Answer: C

Rationale: In the context of lifespan pharmacology, the most appropriate instruction for a patient diagnosed with reflux esophagitis (GERD) is to try proton-pump inhibitors for 2 weeks (Option C). This is the correct answer because proton-pump inhibitors are the first-line treatment for GERD due to their effectiveness in reducing stomach acid production and providing relief from symptoms. Option A is incorrect because exercising soon after eating can actually worsen GERD symptoms by increasing gastric emptying and promoting reflux. Option B is not the most immediate or necessary instruction for managing GERD unless there are specific indications for an upper GI endoscopy. Option D is also incorrect as over-the-counter antiemetics are not the primary treatment for GERD; they may provide symptomatic relief for nausea or vomiting but do not address the underlying cause of GERD. From an educational perspective, it is important for healthcare providers to understand the rationale behind treatment options for GERD to provide optimal care for patients. Proton-pump inhibitors are recommended as the initial pharmacological treatment for GERD due to their efficacy in managing symptoms and promoting healing of the esophagus. Educating patients on the appropriate use of medications and lifestyle modifications is crucial in the management of GERD to improve patient outcomes and quality of life.

Question 5 of 5

Which of the following is (are) true of Vitamin B-3? (select all the apply).

Correct Answer: A

Rationale: In the context of Lifespan Pharmacology, understanding the properties and effects of different vitamins, including Vitamin B-3 (niacin), is crucial for healthcare professionals. In this question, option A is correct because Vitamin B-3 can indeed be used to raise HDL (good cholesterol) levels. Niacin is known to have this lipid-modifying effect, which is beneficial in managing dyslipidemia and reducing cardiovascular risk. Option B is incorrect because the administration of high doses of niacin can indeed cause flushing as a common side effect. This side effect is often seen with immediate-release formulations and can be uncomfortable for patients, leading to poor adherence. Option C is incorrect because a deficiency in Vitamin B-3 typically results in pellagra, not beriberi. Pellagra is characterized by symptoms such as dermatitis, diarrhea, and dementia, whereas beriberi is caused by a deficiency in Vitamin B-1 (thiamine). Option D is incorrect because Vitamin B-6, not Vitamin B-3, is the recommended supplement for patients on long-term Isoniazid therapy to prevent peripheral neuropathy, a known side effect of the medication. Educationally, this question highlights the importance of understanding the specific roles and effects of different vitamins, as well as common side effects and deficiencies associated with Vitamin B-3. It reinforces the need for healthcare providers to make informed decisions regarding vitamin supplementation based on individual patient needs and medical conditions.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions